Genetic & Immunological Aspects of Diabetes

It is believed that a large proportion of cases of type 1 diabetes result from the autoimmune destruction of the pancreatic β cells. Genetic marker that makes person susceptible to diabetes is located on chromosome 6, and it’s an HLA (human leukocyte antigen) complex. Several HLA complexes have been connected to type 1 diabetes, and if the people have one or more of those, may develop type 1diabities. Fulminant type 1 diabetes (FT1D) is a novel subtype of type 1 diabetes characterized by extremely rapid onset and complete deficiency of insulin due to the destruction of pancreatic β cells. It has been proposed that locally produced MCP-1 may be involved in the development of diabetic nephropathy
A study also suggests that diabetes might be linked to genetics. To date, numerous mutations have been shown to affect type 2 diabetes risks. Genes associated with type 2 diabetes are:
  • TCF7L2, which affects insulin secretion and glucose production
  • ABCC8, which helps regulate insulin
  • CAPN10, which is associated with type 2 diabetes risk in Mexican-Americans
  • GLUT2, which helps move glucose into the pancreas
  • GCGR, a glucagon hormone involved in glucose regulation

    Related Conference of Genetic & Immunological Aspects of Diabetes

    January 27-28, 2025

    29th International Conference on Diabetes, Endocrinology and Healthcare

    Dubai, UAE
    February 24-25, 2025

    34th European Diabetes Congress

    London, UK
    February 24-25, 2025

    20th International Conference on Endocrinology and Metabolic Disorders

    London, UK
    March 10-11, 2025

    18th European Diabetes and Endocrinology Congress

    Rome, Italy
    March 10-11, 2025

    4th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    March 17-18, 2025

    5th European Endocrinology and Diabetes Congress

    Paris, France
    March 17-18, 2025

    19th International Conference on Endocrinology, Diabetes and Metabolism

    Singapore City, Singapore
    March 24-25, 2025

    6th Global summit on Diabetes and Endocrinology

    London, UK
    April 07-08, 2025

    36th International Congress on Prevention of Diabetes and Complications

    Vancouver, Canada
    April 10-11, 2025

    31st International Conference on Human Metabolic Health- Diabetes, Obesity & Endocrinology

    Dubai, UAE
    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    April 10-11, 2025

    27th World Congress on Diabetes and Endocrine Disorders

    Dubai, UAE
    April 10-11, 2025

    4th International Summit on Hormonal Disorders

    Dubai, UAE
    April 16-17, 2025

    9th International Conference on Diabetes and Cholesterol Metabolism

    Tokyo, Japan
    May 05-06, 2025

    24th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders

    Rome, Italy
    May 12-13, 2025

    2nd International Congress on Endocrinology and Complications of Diabetes

    Rome, Italy
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy
    June 04-05, 2025

    4th World Congress on Diabetes and Pediatric Endocrinology

    Edinburgh, Scotland
    June 24-25, 2025

    23rd Global Conference on Diabetes, Endocrinology and Primary Healthcare

    Paris, France
    July 29-30, 2025

    15th World Congress on Endocrinology and Diabetes

    Aix-en-Provence, France
    August 11-12, 2025

    5th International Conference on Endocrinology and Diabetes

    Toronto, Canada
    September 08-09, 2025

    3rd World congress and Expo on Diabetes

    Frankfurt, Germany
    November 06-07, 2025

    34th International Conference on Clinical Diabetes, Diabetic Medication & Treatment

    Berlin, Germany
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Aix-en-Provence, France

    Genetic & Immunological Aspects of Diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in